{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T19:49:25Z","timestamp":1648583365106},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:00:00Z","timestamp":1552003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00104-019-0921-5","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T08:35:28Z","timestamp":1552034128000},"page":"441-446","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systematik in der Operationsplanung bei Weichgewebesarkomen der Extremit\u00e4ten"],"prefix":"10.1007","volume":"90","author":[{"given":"J.","family":"Jakob","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Schmolders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,8]]},"reference":[{"key":"921_CR1","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/cncr.30370","volume":"123","author":"D Berger-Richardson","year":"2017","unstructured":"Berger-Richardson D, Swallow CJ (2017) Needle tract seeding after percutaneous biopsy of sarcoma: risk\/benefit considerations. Cancer 123:560\u2013567","journal-title":"Cancer"},{"key":"921_CR2","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1093\/annonc\/mdx484","volume":"28","author":"JY Blay","year":"2017","unstructured":"Blay JY, Soibinet P, Penel N et\u00a0al (2017) Improved survival using specialized multidisciplinary board in sarcoma patients. Ann Oncol 28:2852\u20132859","journal-title":"Ann Oncol"},{"key":"921_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1470-2045(16)00010-3","volume":"17","author":"D Callegaro","year":"2016","unstructured":"Callegaro D, Miceli R, Bonvalot S et al (2016) Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a\u00a0retrospective analysis. Lancet Oncol 17:671\u2013680","journal-title":"Lancet Oncol"},{"key":"921_CR4","doi-asserted-by":"publisher","first-page":"iv51","DOI":"10.1093\/annonc\/mdy096","volume":"29","author":"PG Casali","year":"2018","unstructured":"Casali PG, Abecassis N, Bauer S et al (2018) Soft tissue and visceral sarcomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 29:iv51\u2013iv67","journal-title":"Ann Oncol"},{"key":"921_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-018-5845-9","author":"A Chhabra","year":"2018","unstructured":"Chhabra A, Ashikyan O, Slepicka C et al (2018) Conventional MR and diffusion-weighted imaging of musculoskeletal soft tissue malignancy: correlation with histologic grading. Eur Radiol. \n                    https:\/\/doi.org\/10.1007\/s00330-018-5845-9","journal-title":"Eur Radiol"},{"key":"921_CR6","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1200\/JCO.2002.03.084","volume":"20","author":"AM Davis","year":"2002","unstructured":"Davis AM, O\u2019sullivan B, Bell RS et\u00a0al (2002) Function and health status outcomes in a\u00a0randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J\u00a0Clin Oncol 20:4472\u20134477","journal-title":"J Clin Oncol"},{"key":"921_CR7","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s00256-017-2745-z","volume":"46","author":"M Hoz Polo De La","year":"2017","unstructured":"De La Hoz Polo M, Dick E, Bhumbra R et\u00a0al (2017) Surgical considerations when reporting MRI studies of soft tissue sarcoma of the limbs. Skeletal Radiol 46:1667\u20131678","journal-title":"Skeletal Radiol"},{"key":"921_CR8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1245\/s10434-017-6240-5","volume":"25","author":"DJ Erstad","year":"2018","unstructured":"Erstad DJ, Ready J, Abraham J et\u00a0al (2018) Amputation for extremity sarcoma: contemporary indications and outcomes. Ann Surg Oncol 25:394\u2013403","journal-title":"Ann Surg Oncol"},{"key":"921_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bjps.2015.01.002","volume":"68","author":"S Fischer","year":"2015","unstructured":"Fischer S, Soimaru S, Hirsch T et\u00a0al (2015) Local tendon transfer for knee extensor mechanism reconstruction after soft tissue sarcoma resection. J\u00a0Plast Reconstr Aesthet Surg 68:729\u2013735","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"921_CR10","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1302\/0301-620X.97B9.35192","volume":"97-b","author":"S Furtado","year":"2015","unstructured":"Furtado S, Grimer RJ, Cool P et al (2015) Physical functioning, pain and quality of life after amputation for musculoskeletal tumours: a\u00a0national survey. Bone Joint J 97-b:1284\u20131290","journal-title":"Bone Joint J."},{"key":"921_CR11","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S1470-2045(17)30334-0","volume":"18","author":"A Gronchi","year":"2017","unstructured":"Gronchi A, Ferrari S, Quagliuolo V et al (2017) Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol 18:812\u2013822","journal-title":"Lancet Oncol"},{"key":"921_CR12","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1200\/JCO.2017.74.6941","volume":"36","author":"KR Gundle","year":"2018","unstructured":"Gundle KR, Kafchinski L, Gupta S et\u00a0al (2018) Analysis of margin classification systems for assessing the risk of local recurrence after soft tissue sarcoma resection. J\u00a0Clin Oncol 36:704\u2013709","journal-title":"J Clin Oncol"},{"key":"921_CR13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ijrobp.2012.01.062","volume":"84","author":"RL Haas","year":"2012","unstructured":"Haas RL, Delaney TF, O\u2019sullivan B et\u00a0al (2012) Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where? Int J Radiat Oncol Biol Phys 84:572\u2013580","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"921_CR14","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1634\/theoncologist.2016-0498","volume":"22","author":"K Harati","year":"2017","unstructured":"Harati K, Goertz O, Pieper A et\u00a0al (2017) Soft tissue sarcomas of the extremities: surgical margins can be close as long as the resected tumor has no ink on it. Oncologist 22:1400\u20131410","journal-title":"Oncologist"},{"key":"921_CR15","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1002\/cncr.29991","volume":"122","author":"J Jakob","year":"2016","unstructured":"Jakob J, Hohenberger P (2016) Role of isolated limb perfusion with recombinant human tumor necrosis factor alpha and melphalan in locally advanced extremity soft tissue sarcoma. Cancer 122:2624\u20132632","journal-title":"Cancer"},{"key":"921_CR16","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.ejso.2016.03.026","volume":"42","author":"V Kainhofer","year":"2016","unstructured":"Kainhofer V, Smolle MA, Szkandera J et\u00a0al (2016) The width of resection margins influences local recurrence in soft tissue sarcoma patients. Eur J Surg Oncol 42:899\u2013906","journal-title":"Eur J Surg Oncol"},{"key":"921_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2018.09.001","author":"J Lansu","year":"2018","unstructured":"Lansu J, Groenewegen J, Van Coevorden F et\u00a0al (2018) Time dependent dynamics of wound complications after preoperative radiotherapy in extremity soft tissue sarcomas. Eur J Surg Oncol. \n                    https:\/\/doi.org\/10.1016\/j.ejso.2018.09.001","journal-title":"Eur J Surg Oncol"},{"key":"921_CR18","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/S0140-6736(02)09292-9","volume":"359","author":"B O\u2019sullivan","year":"2002","unstructured":"O\u2019sullivan B, Davis AM, Turcotte R et al (2002) Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a\u00a0randomised trial. Lancet 359:2235\u20132241","journal-title":"Lancet"},{"key":"921_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejca.2018.01.071","volume":"93","author":"S Pasquali","year":"2018","unstructured":"Pasquali S, Colombo C, Pizzamiglio S et al (2018) High-risk soft tissue sarcomas treated with perioperative chemotherapy: improving prognostic classification in a\u00a0randomised clinical trial. Eur J Cancer 93:28\u201336","journal-title":"Eur J Cancer"},{"key":"921_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1472-6963-12-82","volume":"12","author":"L Perrier","year":"2012","unstructured":"Perrier L, Buja A, Mastrangelo G et al (2012) Clinicians\u2019 adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a\u00a0cost-effectiveness assessment in two European regions. BMC Health Serv Res 12:82","journal-title":"BMC Health Serv Res"},{"key":"921_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/2047-783X-17-29","volume":"17","author":"F Pohlig","year":"2012","unstructured":"Pohlig F, Kirchhoff C, Lenze U et\u00a0al (2012) Percutaneous core needle biopsy versus open biopsy in diagnostics of bone and soft tissue sarcoma: a\u00a0retrospective study. Eur J Med Res 17:29","journal-title":"Eur J Med Res"},{"key":"921_CR22","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1245\/s10434-011-1876-z","volume":"19","author":"YA Qureshi","year":"2012","unstructured":"Qureshi YA, Huddy JR, Miller JD et\u00a0al (2012) Unplanned excision of soft tissue sarcoma results in increased rates of local recurrence despite full further oncological treatment. Ann Surg Oncol 19:871\u2013877","journal-title":"Ann Surg Oncol"},{"key":"921_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12889-018-5131-4","volume":"18","author":"M Ressing","year":"2018","unstructured":"Ressing M, Wardelmann E, Hohenberger P et\u00a0al (2018) Strengthening health data on a\u00a0rare and heterogeneous disease: sarcoma incidence and histological subtypes in Germany. BMC Public Health 18:235","journal-title":"BMC Public Health"},{"key":"921_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1245\/s10434-017-5895-2","volume":"25","author":"HG Smith","year":"2018","unstructured":"Smith HG, Thomas JM, Smith MJF et al (2018) Major amputations for extremity soft-tissue sarcoma. Ann Surg Oncol 25:387\u2013393","journal-title":"Ann Surg Oncol"},{"key":"921_CR25","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1308\/rcsann.2015.0002","volume":"97","author":"MA Smolle","year":"2015","unstructured":"Smolle MA, Leithner A, Grimer RJ (2015) Evaluating the British sarcoma referral form. Ann R Coll Surg Engl 97:434\u2013438","journal-title":"Ann R Coll Surg Engl"},{"key":"921_CR26","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1245\/s10434-017-5776-8","volume":"24","author":"MA Smolle","year":"2017","unstructured":"Smolle MA, Tunn PU, Goldenitsch E et\u00a0al (2017) The prognostic impact of unplanned excisions in a\u00a0cohort of 728 soft tissue sarcoma patients: a multicentre study. Ann Surg Oncol 24:1596\u20131605","journal-title":"Ann Surg Oncol"},{"key":"921_CR27","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.bjps.2013.06.029","volume":"66","author":"WA Townley","year":"2013","unstructured":"Townley WA, Mah E, O\u2019Neill AC et al (2013) Reconstruction of sarcoma defects following pre-operative radiation: free tissue transfer is safe and reliable. J Plast Reconstr Aesthet Surg 66:1575\u20131579","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"921_CR28","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1002\/cncr.31648","volume":"124","author":"F Traub","year":"2018","unstructured":"Traub F, Griffin AM, Wunder JS et al (2018) Influence of unplanned excisions on the outcomes of patients with stage III extremity soft-tissue sarcoma. Cancer 124:3868\u20133875","journal-title":"Cancer"},{"key":"921_CR29","doi-asserted-by":"publisher","first-page":"536","DOI":"10.6004\/jnccn.2018.0025","volume":"16","author":"M Mehren Von","year":"2018","unstructured":"Von Mehren M, Randall RL, Benjamin RS et\u00a0al (2018) Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology. J\u00a0Natl Compr Canc Netw 16:536\u2013563","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"921_CR30","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1470-2045(12)70346-7","volume":"13","author":"PJ Woll","year":"2012","unstructured":"Woll PJ, Reichardt P, Le Cesne A et al (2012) Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a\u00a0multicentre randomised controlled trial. Lancet Oncol 13:1045\u20131054","journal-title":"Lancet Oncol"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-019-0921-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00104-019-0921-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-019-0921-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T00:13:43Z","timestamp":1583540023000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00104-019-0921-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,8]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["921"],"URL":"https:\/\/doi.org\/10.1007\/s00104-019-0921-5","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,8]]},"assertion":[{"value":"8 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Jakob erhielt Vortragshonorare der Firma Lilly Deutschland. J.\u00a0Schmolders gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}